CC
ELV icon

Centiva Capital’s Elevance Health ELV Stock Holding History

Centiva Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,200
Closed -$579K – 1583
2022
Q2 		$579K Hold
1,200
– – 0.01% 852
2022
Q1 		$589K Sell
1,200
-800
-40% -$366K 0.01% 901
2021
Q4 		$927K Buy
2,000
+1,800
+900% +$757K 0.02% 653
2021
Q3 		$75K Buy
+200
New +$76K ﹤0.01% 1101

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Centiva Capital's ELV Position: Q2 2026 in Review

Centiva Capital increased its Elevance Health (ELV) stake by 37% in Q2 2026, buying an estimated $109K and bringing the position to 1,093 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.

Centiva Capital first reported a position in ELV in Q4 2019 and has held it in 17 quarters since. The position peaked at $3.88M in Q3 2024. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Centiva Capital held 1,093 shares of Elevance Health worth $423K as of Q2 2026.
  • Centiva Capital bought 293 Elevance Health shares in Q2 2026, an estimated $109K.
  • Elevance Health made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1000 holding.
  • Centiva Capital first reported a position in Elevance Health in Q4 2019 and has held it in 17 quarters since.
  • Centiva Capital's Elevance Health position peaked at $3.88M in Q3 2024.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.